The aim of the CELPPLUS project is to improve screening of potential drug candidates for various diseases. To do so, the CELPPLUS team will develop a new technology with controlled microenvironments for 2D cell cultures. This will allow researchers tobetter mimics in vivo cells than with the current technologies. The CELPPLUS project involves industry partners from LEO Pharma.

On this page, you can find all of the news from ODIN, which is related to the CELPPLUS project. If you are more curious about the project, you can always contact head of the CELPPLUS project Duncan Sutherland,.

CELPPLUS is short for "Advanced 2D CELL culture for improved Phenotype assays"